These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6620296)

  • 1. Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist.
    Cohen SA; Neumeyer JL
    J Med Chem; 1983 Oct; 26(10):1348-53. PubMed ID: 6620296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptors modulating [3H]acetylcholine release in slices of the cat caudate: effects of (-)-N-(2-chloroethyl)-norapomorphine.
    Lehmann J; Lee CR; Langer SZ
    Eur J Pharmacol; 1983 Jun; 90(4):393-400. PubMed ID: 6884428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application.
    Guan JH; Neumeyer JL; Filer CN; Ahern DG; Lilly L; Watanabe M; Grigoriadis D; Seeman P
    J Med Chem; 1984 Jun; 27(6):806-10. PubMed ID: 6737423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
    Baldessarini RJ; Kula NS; Arana GW; Neumeyer JL; Law SJ
    Eur J Pharmacol; 1980 Oct; 67(1):105-10. PubMed ID: 7418727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of solvolysis and muscarinic actions of an N-methyl-N-(2-bromoethyl)amino analogue of oxotremorine.
    Ringdahl B; Jenden DJ
    J Med Chem; 1987 May; 30(5):852-4. PubMed ID: 3572973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
    Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
    J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (-)-N-(2-chloroethyl)-norapomorphine.
    Lehmann J; Langer SZ
    Eur J Pharmacol; 1982 Jan; 77(1):85-6. PubMed ID: 7060630
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue.
    Baldessarini RJ; Kula NS
    Life Sci; 1983 Aug; 33(8):769-78. PubMed ID: 6193387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
    Griffin MT; Thomas EA; Ehlert FJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):301-5. PubMed ID: 8331565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding.
    Costall B; Fortune DH; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    Nature; 1980 Jun; 285(5766):571-3. PubMed ID: 7402299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions.
    Shulman-Roskes EM; Noe DA; Gamcsik MP; Marlow AL; Hilton J; Hausheer FH; Colvin OM; Ludeman SM
    J Med Chem; 1998 Feb; 41(4):515-29. PubMed ID: 9484502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
    Ransom RW; Kammerer RC; Cho AK
    Mol Pharmacol; 1982 Mar; 21(2):380-6. PubMed ID: 7099142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
    Bolton MG; Hilton J; Robertson KD; Streeper RT; Colvin OM; Noe DA
    Drug Metab Dispos; 1993; 21(6):986-96. PubMed ID: 7905404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible inhibitors of nicotinic acetylcholine receptors: isolation and structural characterization of the biologically active solvolysis products of bipinnatin-A and bipinnatin-C.
    Hyde EG; Boyer A; Tang P; Xu Y; Abramson SN
    J Med Chem; 1995 Jun; 38(12):2231-8. PubMed ID: 7783154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.